Fennec Pharmaceuticals's total assets for Q3 2024 were $58.92M, a decrease of -6.71% from the previous quarter. FENC total liabilities were $64.09M for the fiscal quarter, a -0.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.